Skip to main content

Table 3 Cervical cancer-specific mortality by ethnicity adjusted for comorbidity

From: Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study

   Ethnicity
Comorbidities Comorbidity Other Māori Pacific Asian
  HR (95%CI) a HR (95%CI) b HR (95%CI) c HR (95%CI) c HR (95%CI) c
No comorbidity adjustment/inclusion   1.00 1.56 (1.19-2.05) 1.95 (1.21-3.13) 0.72 (0.41-1.27)
Elixhauser as continuous variable 1.25 (1.11-1.40) 1.00 1.55 (1.19-2.04) 1.92 (1.20-3.09) 0.72 (0.41-1.26)
Individual comorbities      
   Congestive heart failure 2.35 (1.22-4.52) 1.00 1.57 (1.20-2.06) 1.98 (1.23-3.17) 0.72 (0.41-1.27)
   Valvular disease 2.84 (0.70-11.61) 1.00 1.56 (1.19-2.04) 1.96 (1.22-3.14) 0.72 (0.41-1.27)
   Hypertension, complicated 1.74 (0.24-12.72) 1.00 1.57 (1.19-2.06) 1.95 (1.22-3.13) 0.72 (0.41-1.27)
   Chronic pulmonary disease 1.62 (0.95-2.77) 1.00 1.55 (1.18-2.03) 1.95 (1.22-3.13) 0.67 (0.38-1.19)
   Diabetes, complicated 10.46 (3.01-36.37) 1.00 1.55 (1.18-2.04) 1.70 (1.03-2.80) 0.71 (0.40-1.25)
   Renal failure 4.27 (2.08-8.76) 1.00 1.58 (1.20-2.07) 1.70 (1.04-2.77) 0.72 (0.41-1.27)
   Liver disease 2.43 (0.76-7.78) 1.00 1.55 (1.18-2.03) 1.92 (1.20-3.09) 0.72 (0.41-1.26)
   Coagulopathy 2.78 (0.68-11.43) 1.00 1.55 (1.18-2.03) 1.91 (1.19-3.07) 0.72 (0.41-1.27)
   Obesity 3.52 (1.55-7.98) 1.00 1.55 (1.18-2.04) 1.90 (1.18-3.05) 0.72 (0.41-1.27)
   Fluid and electrolyte disorders 4.03 (2.01-8.08) 1.00 1.51 (1.15-1.98) 1.97 (1.23-3.16) 0.69 (0.39-1.21)
   Blood loss anaemia 2.44 (1.48-4.00) 1.00 1.53 (1.17-2.01) 1.98 (1.23-3.17) 0.71 (0.40-1.26)
   Drug abuse 3.28 (0.45-23.76) 1.00 1.56 (1.19-2.04) 1.95 (1.22-3.13) 0.72 (0.41-1.27)
Multivariate - all 12 of the above   1.00 1.44 (1.09-1.89) 1.62 (0.98-2.68) 0.63 (0.35-1.13)
  1. a Adjusted for age, year of diagnosis, stage, ethnicity, socioeconomic position, and urban/rural residence
  2. b Reference category
  3. c Adjusted for age, year of diagnosis, stage, ethnicity, socioeconomic position, urban/rural residence, and comorbidity index